The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
The metabolic syndrome: time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Self-citationC-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Danesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
Standards of Medical Care in Diabetes–2006
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s4 · Cited by 1,885
Malik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L’Italien, G. J., Pio, J. R., & Williams, G. R. (2004) · Circulation · doi:10.1161/01.cir.0000140677.20606.0e · Cited by 1,848
Obesity-induced inflammatory changes in adipose tissue
Wellen, K. E., & Hotamisligil, G. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320514 · Cited by 1,823
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
Association of Hypoadiponectinemia With Coronary Artery Disease in Men
Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, I., Hiraoka, H., et al. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000048856.22331.50 · Cited by 1,420
Albuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
The IDF consensus worldwide definition of the metabolic syndrome
- (2005) · Obesity and metabolism · doi:10.14341/2071-8713-4854 · Cited by 1,391
Diabetes and cardiovascular risk factors: the Framingham study
Kannel, W. B., & McGee, D. L. (1979) · Circulation · doi:10.1161/01.cir.59.1.8 · Cited by 1,317
Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X)
Haffner, S. M., Valdez, R. A., Hazuda, H. P., Mitchell, B. D., Morales, P. A., & Stern, M. P. (1992) · Diabetes · doi:10.2337/diab.41.6.715 · Cited by 1,238
Self-citationPathophysiology of insulin resistance in human disease
Reaven, G. M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.473 · Cited by 1,226
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084 · cited 4×
“This problem stands in contrast to the Framingham [95] and UKPDS [99] risk models, in which the spectrum of severities is weighted, so that it is clear who may be at greater or lesser risk.”
InfluentialAmerican College of Endocrinology Position Statement on the Insulin Resistance Syndrome
Einhorn, D. (2003) · Endocrine Practice · doi:10.4158/ep.9.s2.5 · Cited by 1,066
McNeill, A. M., Rosamond, W. D., Girman, C. J., Golden, S. H., Schmidt, M. I., East, H. E., Ballantyne, C. M., & Heiss, G. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.385 · Cited by 1,054
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
Adiponectin: More Than Just Another Fat Cell Hormone?
Chandran, M., Phillips, S. A., Ciaraldi, T., & Henry, R. R. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2442 · Cited by 1,008
Carr, D. B., Utzschneider, K. M., Hull, R. L., Kodama, K., Retzlaff, B. M., Brunzell, J. D., Shofer, J. B., Fish, B. E., Knopp, R. H., & Kahn, S. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2087 · Cited by 993
Fibrinogen as a Cardiovascular Risk Factor: A Meta-Analysis and Review of the Literature
Ernst, E., & Resch, K. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00008 · Cited by 990
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome
Ferrannini, E., Haffner, S. M., Mitchell, B. D., & Stern, M. P. (1991) · Diabetologia · doi:10.1007/bf00403180 · Cited by 898
Self-citationDetection of Epstein–Barr Viral Genomes in Reed–Sternberg Cells of Hodgkin's Disease
Weiss, L. M., Movahed, L. A., Warnke, R. A., & Sklar, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200806 · Cited by 886
Haffner, S. M., Greenberg, A. S., Weston, W. M., Chen, H., Williams, K., & Freed, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000025403.20953.23 · Cited by 884
Grundy, S. M., Hansen, B., Smith, S. C., Cleeman, J. I., Kahn, R. A., & Participants, F. C. (2004) · Circulation · doi:10.1161/01.cir.0000112379.88385.67 · Cited by 864
Self-citationZimmet, P., Alberti, K. G. M. M., & Serrano Ríos, M. (2005) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60742-1 · Cited by 864
CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall Study
Fuller, J., Shipley, M., Rose, G., Jarrett, R. J., & Keen, H. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92651-3 · Cited by 783
Zavaroni, I., Bonora, E., Pagliara, M., Dall'Aglio, E., Luchetti, L., Buonanno, G., Bonati, P. A., Bergonzani, M., Gnudi, L., Passeri, M., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201105 · Cited by 771
Pyörälä, K. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.131 · Cited by 768
Zoccali, C., Mallamaci, F., Tripepi, G., Benedetto, F. A., Cutrupi, S., Parlongo, S., Malatino, L. S., Bonanno, G., Seminara, G., Rapisarda, F., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131134 · Cited by 761
Ducimetiere, P., Eschwege, E., Papoz, L., Richard, J. L., Claude, J. R., & Rosselin, G. (1980) · Diabetologia · doi:10.1007/bf00275270 · Cited by 747
Stern, M. P., Williams, K., González-Villalpando, C., Hunt, K. J., & Haffner, S. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2676 · Cited by 735
Welborn, T. A., & Wearne, K. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.154 · Cited by 735
Insulin Sensitivity and Atherosclerosis
Howard, G., O’Leary, D. H., Zaccaro, D., Haffner, S., Rewers, M., Hamman, R., Selby, J. V., Saad, M. F., Savage, P., & Bergman, R. (1996) · Circulation · doi:10.1161/01.cir.93.10.1809 · Cited by 729
Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. F. (2004) · Circulation · doi:10.1161/01.cir.0000136581.59584.0e · Cited by 664 · cited 2×
“drome, and incident cardiovascular events [68, 73, 74].”
Hunt, K. J., Resendez, R. G., Williams, K., Haffner, S. M., & Stern, M. P. (2004) · Circulation · doi:10.1161/01.cir.0000140762.04598.f9 · Cited by 662
Self-citationRidker, P. M., Wilson, P. W. F., & Grundy, S. M. (2004) · Circulation · doi:10.1161/01.cir.0000132467.45278.59 · Cited by 645
Lachenbruch, P. A., Mardia, K. V., Kent, J. T., & Bibby, J. M. (1981) · Biometrics · doi:10.2307/2530538 · Cited by 630
Aronoff, S., Rosenblatt, S., Braithwaite, S., Egan, J. W., Mathisen, A. L., & Schneider, R. L. (2000) · Diabetes Care · doi:10.2337/diacare.23.11.1605 · Cited by 629
A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions
Ford, E. S., & Giles, W. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.575 · Cited by 616
Insulin resistance as a predictor of age-related diseases
Facchini, F. S., Hua, N., Abbasi, F., & Reaven, G. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7763 · Cited by 594
Decreased Plasma Adiponectin Concentrations in Women with Dyslipidemia
Matsubara, M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2764 · Cited by 544
Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study
Meigs, J. B., D'Agostino, R. B., Wilson, P. W., Cupples, L. A., Nathan, D. M., & Singer, D. E. (1997) · Diabetes · doi:10.2337/diabetes.46.10.1594 · Cited by 527
Girman, C. J., Rhodes, T., Mercuri, M., Pyörälä, K., Kjekshus, J., Pedersen, T. R., Beere, P. A., Gotto, A. M., & Clearfield, M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.028 · Cited by 526
Balkau, B., Charles, M.-A. A., Drivsholm, T., Borch‐Johnsen, K., Wareham, N. J., Yudkin, J. S., Morris, R. W., Zavaroni, I., van Dam, R. M., Feskins, E., et al. (2002) · PubMed · Cited by 525
Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes
Lebovitz, H. E., Dole, J., Patwardhan, R., Rappaport, E. B., & Freed, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.280 · Cited by 518
Role of Insulin in Endogenous Hypertriglyceridemia*
Reaven, G. M., Lerner, R. L., Stern, M. P., & Farquhar, J. W. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105666 · Cited by 511
Self-citationFord, E. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.12.022 · Cited by 501
Shen, S.-W., Reaven, G. M., & Farquhar, J. W. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106433 · Cited by 494
Reappraisal of the role of insulin in hypertriglyceridemia
Olefsky, J. M., Farquhar, J. W., & Reaven, G. M. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90006-0 · Cited by 482
Components of the Metabolic Syndrome and Risk of Cardiovascular Disease and Diabetes in Beaver Dam
Klein, B. E. K., Klein, R., & Lee, K. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1790 · Cited by 468
Meigs, J. B., Wilson, P. W. F., Nathan, D. M., D’Agostino, R. B., Williams, K., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2160 · Cited by 464
Haffner, S. M., Mykkänen, L., Festa, A., Burke, J. P., & Stern, M. P. (2000) · Circulation · doi:10.1161/01.cir.101.9.975 · Cited by 457
Self-citationHimsworth, H. P. (1936) · The Lancet · doi:10.1016/s0140-6736(01)36134-2 · Cited by 441
Zoccali, C., Mallamaci, F., & Finocchiaro, P. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032548.18973.0f · Cited by 428
Resnick, H. E., Jones, K., Ruotolo, G., Jain, A. K., Henderson, J., Lu, W., & Howard, B. V. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.861 · Cited by 427
Sakkinen, P. A., Wahl, P., Cushman, M., Lewis, M. R., & Tracy, R. P. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.897 · Cited by 420
Yeni-Komshian, H., Carantoni, M., Abbasi, F., & Reaven, G. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.171 · Cited by 414
Katzmarzyk, P. T., Church, T. S., & Blair, S. N. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1092 · Cited by 408
Factor Analysis: An Applied Approach
Jackson, J. E. (1985) · Technometrics · doi:10.1080/00401706.1985.10488039 · Cited by 401
Identification of Individuals With Insulin Resistance Using Routine Clinical Measurements
Stern, S. E., Williams, K., Ferrannini, E., DeFronzo, R. A., Bogardus, C., & Stern, M. P. (2005) · Diabetes · doi:10.2337/diabetes.54.2.333 · Cited by 384
Self-citationDevelopment of the Multiple Metabolic Syndrome: An Epidemiologic Perspective
Liese, A. D., Mayer-Davis, E. J., & Haffner, S. M. (1998) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017978 · Cited by 380
Fontbonne, A., Charles, M. A., Thibult, N., Richard, J. L., Claude, J. R., Warnet, J. M., Rosselin, G. E., & Eschw�ge, E. (1991) · Diabetologia · doi:10.1007/bf00405009 · Cited by 377
Smith, S. C., Jackson, R., Pearson, T. A., Fuster, V., Yusuf, S., Faergeman, O., Wood, D. A., Alderman, M., Horgan, J., Home, P., et al. (2004) · Circulation · doi:10.1161/01.cir.0000133427.35111.67 · Cited by 376
Differentiation Between Obesity and Insulin Resistance in the Association With C-Reactive Protein
McLaughlin, T., Abbasi, F., Lamendola, C., Liang, L., Reaven, G., Schaaf, P., & Reaven, P. (2002) · Circulation · doi:10.1161/01.cir.0000041046.32962.86 · Cited by 373
Resistance to Insulin-Mediated Glucose Disposal as a Predictor of Cardiovascular Disease
Yip, J. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2773 · Cited by 360
Pyörälä, M., Miettinen, H., Halonen, P., Laakso, M., & Pyörälä, K. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.538 · Cited by 349
Pyörälä, M., Miettinen, H., Laakso, M., & Pyörälä, K. (1998) · Circulation · doi:10.1161/01.cir.98.5.398 · Cited by 349
Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease.
Stern, M. P., & Haffner, S. M. (1986) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.6.2.123 · Cited by 331
Self-citationOnat, A., Ceyhan, K., Başar, Ö., Erer, B., Toprak, S., & Sansoy, V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00236-8 · Cited by 316
Cheal, K. L., Abbasi, F., Lamendola, C., McLaughlin, T., Reaven, G. M., & Ford, E. S. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1195 · Cited by 312 · cited 1×
“[132] determined that 16% of 443 healthy, non-diabetic subjects were insulin-resistant and/or positive for metabolic syndrome, with a sensitivity, specificity and positive predictive value for metabolic syndrome 1690”
Weyer, C., Hanson, R. L., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2094 · Cited by 299
Haffner, S. M., D'Agostino, R., Mykkänen, L., Tracy, R., Howard, B., Rewers, M., Selby, J., Savage, P. J., & Saad, M. F. (1999) · Diabetes Care · doi:10.2337/diacare.22.4.562 · Cited by 297
Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Nondiabetic Men
Lempiäinen, P., Mykkänen, L., Pyörälä, K., Laakso, M., & Kuusisto, J. (1999) · Circulation · doi:10.1161/01.cir.100.2.123 · Cited by 293
LAWS, A., & REAVEN, G. M. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00494.x · Cited by 291
Uusitupa, M. I., Niskanen, L. K., Siitonen, O., Voutilainen, E., & Pyörälä, K. (1990) · Circulation · doi:10.1161/01.cir.82.1.27 · Cited by 291
Satoh, N., Ogawa, Y., Usui, T., Tagami, T., Kono, S., Uesugi, H., Sugiyama, H., Sugawara, A., Yamada, K., Shimatsu, A., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2493 · Cited by 289
Laakso, M., Sarlund, H., & Mykkänen, L. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.223 · Cited by 286
The Metabolic Syndrome in Older Individuals: Prevalence and Prediction of Cardiovascular Events
Scuteri, A., Najjar, S. S., Morrell, C. H., & Lakatta, E. G. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.882 · Cited by 280
Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus
Olefsky, J. M., Kolterman, O. G., & Scarlett, J. A. (1982) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1982.243.1.e15 · Cited by 277
Folsom, A. R., Szklo, M., Stevens, J., Liao, F., Smith, R., & Eckfeldt, J. H. (1997) · Diabetes Care · doi:10.2337/diacare.20.6.935 · Cited by 276
Kazumi, T., Kawaguchi, A., Sakai, K., Hirano, T., & Yoshino, G. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.971 · Cited by 275
Festa, A., D’Agostino, R., Mykkänen, L., Tracy, R. P., Zaccaro, D. J., Hales, C. N., & Haffner, S. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.562 · Cited by 263
Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics
Haffner, S. M., Fong, D., Hazuda, H. P., Pugh, J. A., & Patterson, J. K. (1988) · Metabolism · doi:10.1016/0026-0495(88)90133-3 · Cited by 254
Marroquin, O. C., Kip, K. E., Kelley, D. E., Johnson, B. D., Shaw, L. J., Bairey Merz, C. N., Sharaf, B. L., Pepine, C. J., Sopko, G., & Reis, S. E. (2004) · Circulation · doi:10.1161/01.cir.0000115517.26897.a7 · Cited by 243
Coronary Heart Disease: Overweight and Obesity as Risk Factors
KEYS, A., ARAVANIS, C., BLACKBURN, H., VAN BUCHEM, F. S. P., BUZINA, R., DJORDJEVIC, B. S., FIDANZA, F., KARVONEN, M. J., MENOTTI, A., PUDDU, V., et al. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-1-15 · Cited by 243
Freed, M. I., Ratner, R., Marcovina, S. M., Kreider, M. M., Biswas, N., Cohen, B. R., & Brunzell, J. D. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02659-0 · Cited by 238
Factor Analysis of Metabolic Syndrome Using Directly Measured Insulin Sensitivity
Hanley, A. J. G., Karter, A. J., Festa, A., D’Agostino, R., Wagenknecht, L. E., Savage, P., Tracy, R. P., Saad, M. F., & Haffner, S. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2642 · Cited by 229
Ginsberg, H., Kimmerling, G., Olefsky, J. M., & Reaven, G. M. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107951 · Cited by 225 · cited 1×
“hyperinsulinaemia was also found to be a key feature of type 2 diabetes [5, 6], as well as hyperlipidaemia [7–9], obesity [10–13] and hypertension [12–14].”
Potter van Loon, B. J., Kluft, C., Radder, J. K., Blankenstein, M. A., & Meinders, A. E. (1993) · Metabolism · doi:10.1016/0026-0495(93)90005-9 · Cited by 225
Metabolic Syndrome as a Predictor of All-Cause and Cardiovascular Mortality in Type 2 Diabetes
Bruno, G., Merletti, F., Biggeri, A., Bargero, G., Ferrero, S., Runzo, C., Prina Cerai, S., Pagano, G., & Cavallo-Perin, P. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2689 · Cited by 224
Liao, Y., Kwon, S., Shaughnessy, S., Wallace, P., Hutto, A., Jenkins, A. J., Klein, R. L., & Garvey, W. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.978 · Cited by 218
C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women
Pradhan, A. D., Cook, N. R., Buring, J. E., Manson, J. E., & Ridker, P. M. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000065636.15310.9c · Cited by 213
The Metabolic Syndrome: Practical Guide to Origins and Treatment: Part I
Wilson, P. W. F., & Grundy, S. M. (2003) · Circulation · doi:10.1161/01.cir.0000089505.34741.e5 · Cited by 212
Schmidt, M. I., Watson, R. L., Duncan, B. B., Metcalf, P., Brancati, F. L., Richey Sharrett, A., Davis, C. E., & Heiss, G. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90134-1 · Cited by 212
Mykkänen, L., Kuusisto, J., Pyörälä, K., & Laakso, M. (1993) · Diabetologia · doi:10.1007/bf02743273 · Cited by 206
Asymptomatic atherosclerosis and insulin resistance.
Laakso, M., Sarlund, H., Salonen, R., Suhonen, M., Pyörälä, K., Salonen, J. T., & Karhapää, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.1068 · Cited by 206
Are Metabolic Risk Factors One Unified Syndrome? Modeling the Structure of the Metabolic Syndrome X
Shen, B.-J. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg045 · Cited by 202
Rosengren, A., Welin, L., Tsipogianni, A., & Wilhelmsen, L. (1989) · BMJ · doi:10.1136/bmj.299.6708.1127 · Cited by 199
Golden, S. H., Folsom, A. R., Coresh, J., Sharrett, A. R., Szklo, M., & Brancati, F. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3069 · Cited by 199
Kojima, S., Funahashi, T., Sakamoto, T., Miyamoto, S., Soejima, H., Hokamaki, J., Kajiwara, I., Sugiyama, S., Yoshimura, M., Fujimoto, K., et al. (2003) · Heart · doi:10.1136/heart.89.6.667 · Cited by 199
(1964) · The Lancet · doi:10.1016/s0140-6736(64)92049-5 · Cited by 197
Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2000) · Diabetologia · doi:10.1007/s001250050023 · Cited by 193
PLASMA INSULIN AND LIPOPROTEIN CONCENTRATIONS: AN ATHEROGENIC ASSOCIATION?
ORCHARD, T. J., BECKER, D. J., BATES, M., KULLER, L. H., & DRASH, A. L. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113639 · Cited by 187
Reilly, M. P., Wolfe, M. L., Rhodes, T., Girman, C., Mehta, N., & Rader, D. J. (2004) · Circulation · doi:10.1161/01.cir.0000138740.84883.9c · Cited by 185
Report of the American Diabetes Association's Task Force on Standardization of the Insulin Assay
Robbins, D. C., Andersen, L., Bowsher, R., Chance, R., Dinesen, B., Frank, B., Gingerich, R., Goldstein, D., Widemeyer, H.-M., Haffner, S., et al. (1996) · Diabetes · doi:10.2337/diab.45.2.242 · Cited by 179
Pyörälä, K., Ballantyne, C. M., Gumbiner, B., Lee, M. W., Shah, A., Davies, M. J., Mitchel, Y. B., Pedersen, T. R., Kjekshus, J., & for the Scandinavian Simvastatin Survival Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1735 · Cited by 169
Risk Factor Clustering in the Insulin Resistance Syndrome: The Strong Heart Study
Gray, R. S., Fabsitz, R. R., Cowan, L. D., Lee, E. T., Howard, B. V., & Savage, P. J. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009712 · Cited by 166
Do Different Dimensions of the Metabolic Syndrome Change Together Over Time?
Maison, P., Byrne, C. D., Hales, C. N., Day, N. E., & Wareham, N. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1758 · Cited by 165
The DECODE Insulin Study Group (2004) · Diabetologia · doi:10.1007/s00125-004-1433-4 · Cited by 161
Is Insulin Really a Heart Disease Risk Factor?
Wingard, D. L., Barrett-Connor, E. L., & Ferrara, A. M. (1995) · Diabetes Care · doi:10.2337/diacare.18.9.1299 · Cited by 152
Plasma Fibrinogen: A New Factor of the Metabolic Syndrome: A population-based study
Imperatore, G., Riccardi, G., Iovine, C., Rivellese, A. A., & Vaccaro, O. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.649 · Cited by 151
Shadid, S., & Jensen, M. D. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3148 · Cited by 150
Hyperinsulinaemia is not a major coronary risk factor in elderly men
Welin, L., Eriksson, H., Larsson, B., Ohlson, L. ‐., Svärdsudd, K., & Tibblin, G. (1992) · Diabetologia · doi:10.1007/bf00429098 · Cited by 138
Asymptomatic atherosclerosis and insulin resistance.
MLaakso, HSarlund, RSalonen, MSuhonen, KPyörälä, TSalonen, J., & PKarhapää (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · Cited by 133
Ferrara, A. M., Barrett-Connor, E. L., & Edelstein, S. L. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117174 · Cited by 130
CLUSTERING OF HEART DISEASE RISK FACTORS IN DIABETIC COMPARED TO NONDIABETIC ADULTS
Wingard, D. L., Barrett-Connor, E. L., Criqui, M. H., & Suarez, L. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113510 · Cited by 126
(Mis)use of Factor Analysis in the Study of Insulin Resistance Syndrome
Lawlor, D. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh150 · Cited by 122
Agewall, S., Fagerberg, B., Attvall, S., Wendelhag, I., Urbanavičius, V., & Wikstrand, J. (1995) · Stroke · doi:10.1161/01.str.26.6.956 · Cited by 120
Schmidt, M. I., Duncan, B. B., Watson, R. L., Sharrett, A. R., Brancati, F. L., HEISS, G. M., & The Atherosclerosis Risk in Communities Study Investigators (1996) · Diabetes Care · doi:10.2337/diacare.19.5.414 · Cited by 115
Associazione di iperlipemia, diabete mellito e obesita' di medio grado
AVOGARO, P., Crepaldi, G., Enzi, G., & Tiengo, A. (1967) · Acta Diabetologica · doi:10.1007/bf01544100 · Cited by 109
Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Type 2 Diabetic Men
Kuusisto, J., Lempiäinen, P. A., Mykkänen, L. M., & Laakso, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1629 · Cited by 109
Insulin: in search of a syndrome
Ferrannini, E., & Balkau, B. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00794.x · Cited by 108
Self-citationOrchard, T. J., Eichner, J. E., Kuller, L. H., Becker, D. J., McCallum, L. M., & Grandits, G. A. (1994) · Annals of Epidemiology · doi:10.1016/1047-2797(94)90041-8 · Cited by 97
Serum Insulin and Incident Coronary Heart Disease in Middle-aged British Men
Perry, I. J., Wannamethee, S. G., Whincup, P. H., Shaper, A. G., Walker, M., & Alberti, K. G. M. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008917 · Cited by 97
Evaluating the performance of the Framingham risk equations in a population with diabetes
McEwan, P. C., Williams, J. E., Griffiths, J. D., Bagust, A., Peters, J. R., Hopkinson, P. K., & Currie, C. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01139.x · Cited by 91
Kekäläinen, P., Sarlund, H., Pyörälà, K., & Laakso, M. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.86 · Cited by 89
Low Insulin Sensitivity is Associated with Clustering of Cardiovascular Disease Risk Factors
Mykkänen, L. M., Haffner, S. M., Ronnemaa, T., Bergman, R. N., & Laakso, M. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009272 · Cited by 84
[Epidermiology and associated risk factors of hyperlipoproteinemia].
Haller, H. (1977) · PubMed · Cited by 80
Wang, J., Qiao, Q., Miettinen, M. E., Lappalainen, J., Hu, G., & Tuomilehto, J. O. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2429 · Cited by 73
Relationship of hypertriglyceridemia to atherosclerosis.
Lippel, K., Tyroler, H. A., Eder, H., Gotto, A. M., & Vahouny, G. V. (1981) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.1.6.406 · Cited by 72
Song, S. H., & Brown, P. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01116.x · Cited by 68
Predicting CHD risk in patients with diabetes mellitus
Yeo, W. W., & Yeo, W. W. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00510.x · Cited by 67
The insulin resistance syndrome: the controversy is dead, long live the controversy!
Stern, M. P. (1994) · Diabetologia · doi:10.1007/bf00400955 · Cited by 67
Self-citationImpact of diabetes/metabolic syndrome in patients with established cardiovascular disease
D, M. P. S. M., Williams, K., & Hunt, K. J. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.02.002 · Cited by 65
YARNELL, J. W. G., Patterson, C. C., Bainton, D., & Sweetnam, P. M. (1998) · Heart · doi:10.1136/hrt.79.3.248 · Cited by 63
Factor Analysis: An Applied Approach.
Harshman, R. A., Cureton, E. E., & D’Agostino, R. B. (1986) · Journal of the American Statistical Association · doi:10.2307/2289034 · Cited by 54
Cybernetics of blood sugar and fat in health and disease
Kadish, A. H. (1967) · Acta Diabetologica · doi:10.1007/bf01543813 · Cited by 38
Factor analysis and defining the metabolic syndrome.
Ford, E. S. (2003) · PubMed · Cited by 31
Fasting Serum Insulin Levels and Coronary Heart Disease in a Danish Cohort: 17-year Follow-up
M??ller, L. F., & Jespersen, J. (1995) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199506000-00009 · Cited by 27
Is Treatment of Insulin Resistance Beneficial Independent of Glycemia?
Davidson, M. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3184 · Cited by 17
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
A comprehensive definition for metabolic syndrome
Huang, P. L. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001180 · Cited by 2,214
Ogden, C. L., Yanovski, S. Z., Carroll, M. D., & Flegal, K. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.052 · Cited by 1,561
Samson, S. L., & Garber, A. J. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.009 · Cited by 746
Regulatory role for the arginine–nitric oxide pathway in metabolism of energy substrates
Jobgen, W. S., Fried, S. K., Fu, W. J., Meininger, C. J., & Wu, G. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.12.001 · Cited by 710
Sleep duration and cardiometabolic risk: A review of the epidemiologic evidence
Knutson, K. L. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.07.001 · Cited by 520
Metadata
- Authors
- Kahn, R., Buse, J., Ferrannini, E., & Stern, M.
- Venue
- Diabetologia
- Published
- 2005-08-04
- Volume
- 48
- Issue
- 9
- Pages
- 1684-1699
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1598025855
- Cited by
- 376
- References
- 176
- FWCI
- 22.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.